The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
NCT ID: NCT02275793
Last Updated: 2019-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2011-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
NCT04019613
Assessing Outcomes in ED Patients With RV Failure
NCT03073629
Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)
NCT01757522
Fluid Status of Outpatients With Dyspnea
NCT02111525
BioImpedentiometry, Lung UltraSound and cONgestion in Heart Failure
NCT02394470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high PH and normal PVR
Group I, diastolic heart failure with high PH and normal PVR
No interventions assigned to this group
high PH and high PVR
Group II, diastolic heart failure with high PH and High PVR
No interventions assigned to this group
normal PH and normal PVR
Group III, no heart failure, normal PH and normal PVR
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide informed consent.
* Presenting for cardiac catheterization for evaluation of heart disease
* Ejection Fraction \> 50%
Exclusion Criteria
* Unable or unwilling to comply with the protocol and follow up.
* Infiltrative cardiomyopathy
* Constrictive pericarditis
* Severe valvular disease
* Comorbid status with life expectancy \<3 years
* Right ventricular dysplasia
* Congenital heart disease
* On immunosuppressive drugs.
* Patients who has heart transplant.
* Ejection Fraction \< 50%
* Mean Pulmonary Artery Pressure \<25
* Wedge pressure \<15
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toledo Health Science Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samer Khouri, MD
Role: PRINCIPAL_INVESTIGATOR
University of Toledo Health Science Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Toledo, Health Science Campus
Toledo, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PVR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.